GIMBEducation
Guida alla scelta dei corsi GIMBE
Nuovo Utente | Recupera PW
Conoscere EBM - Definizione - Acronimi - Cronologia - Ambiti - Know-how e strumenti - EBM in 4 step - Limiti e ostacoli
EB Practice - Formulazione quesito - Ricerca evidenze - Valutazione evidenze - Applicazione evidenze
EBHC Library - Risorse in italiano
SSN Hot Topics - Appropriatezza - Conflitti di interesse - ECM - Farmaci - Governo Clinico - LEA
InfoSanità
Archivio > News 2010
Page last update: 24/01/2012
27 dicembre - 2 gennaio
BMJ, 1 gennaio
Industry sponsored bias in cost effectiveness analyses
20 dicembre - 26 dicembre
N Engl J Med, 23 dicembre
What Is Value in Health Care?
Variability in the Measurement of Hospital-wide Mortality Rates
JAMA 22/29 dicembre
A Behavioral and Systems View of Professionalism
13 - 19 dicembre
BMJ, 18 dicembre
Self experimentation and the Nuremberg Code
Strategies for coping with information overload
On the impossibility of being expert
CMAJ, 14 dicembre
AGREE II: advancing guideline development, reporting and evaluation in health care
6 - 12 dicembre
Ann Intern Med, 7 dicembre
Competency-Based Education and Training in Internal Medicine
29 novembre - 5 dicembre
BMJ, 4 dicembre
Referral from primary to secondary care
Explaining variation in referral from primary to secondary care: cohort study
Lancet, 4 dicembre
A new epoch for health professionals' education
Health professionals for the 21st century: a students' view
Health professionals for a new century: transforming education to strengthen health systems in an interdependent world
N Engl J Med, 2 dicembre
Shattuck Lecture: Innovation, Regulation, and the FDA
JAMA, 1 dicembre
Toward an Outcomes-Based Health Care System: A View From the United Kingdom
22 - 28 novembre
BMJ, 27 novembre
Three techniques for integrating data in mixed methods studies
N Engl J Med, 25 novembre
Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone
Pharmaceutical Marketing and the New Social Media
JAMA, 24 novembre
How to Use an Article About Quality Improvement
The Evolution of Population Science: Advent of the Mega Cohort
Enhancing the Feasibility of Large Cohort Studies
Academic Medical Centers' Conflict of Interest Policies
15 - 21 novembre
BMJ, 20 novembre
The problem of orphan drugs
What makes an orphan drug?
Orphan drug pricing may warrant a competition law investigation
Is open peer review the fairest system? Yes
Is open peer review the fairest system? No
PLoS Med, 16 novembre
Defining Research to Improve Health Systems
Ann Intern Med, 16 novembre
Streamlining Ethical Review
8 - 14 novembre
BMJ, 13 novembre
After the abolition of the National Patient Safety Agency
The future role of NICE
NICE and value based pricing: what do we know?
Drug pricing, NICE, and the PPRS: government gets it right
Health technology assessments: what do differing conclusions tell us?
Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review
Quality Improvement Report. Effect of a “Lean” intervention to improve safety processes and outcomes on a surgical emergency unit
N Engl J Med, 11 novembre
Effect of a Comprehensive Surgical Safety System on Patient Outcomes
Strategies for Improving Surgical Quality — Checklists and Beyond
JAMA, 10 novembre
The Rational Clinical Examination. Does This Patient Have Malaria?
Desktop Medicine
PLoS Med, 9 novembre
Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review
CMAJ, 9 novembre
Substituting placebo for established, effective therapy: Why not?
1 - 7 novembre
BMJ, 6 novembre
Regulation of devices
Lancet. 6 novembre
Drug harms in the UK: a multicriteria decision analysis
N Engl J Med, 4 novembre
Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation
PLoS Med, 2 novembre
Doctors and Drug Companies: Still Cozy after All These Years
Why Do Evaluations of eHealth Programs Fail? An Alternative Set of Guiding Principles
Ann Intern Med, 2 novembre
Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership
25 - 31 ottobre
Lancet, 30 ottobre
Does instant access to compiled information undermine clinical cognition?
JAMA, 27 ottobre
The End of the Quality Improvement Movement: Long Live Improving Value
PLoS Med, 26 ottobre
Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study
Editors, Publishers, Impact Factors, and Reprint Income
Increased Responsibility and Transparency in an Era of Increased Visibility
18 - 24 ottobre
BMJ, 23 ottobre
Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health
N Engl J Med, 21 ottobre
Public Release of Clinical Outcomes Data — Online CABG Report Cards
JAMA, 20 ottobre
Meaningful Use of Electronic Health Records: The Road Ahead
Putting the Public Back in Public Reporting of Health Care Quality
Making Research Consent Transparent
Accountable Care Organizations: Accountable for What, to Whom, and How
Improving Teamwork to Reduce Surgical Mortality
Ann Intern Med, 19 ottobre
What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
CMAJ, 19 ottobre
Registration of observational studies: Is it time?
11 - 17 ottobre
BMJ, 15 ottobre
Missing clinical trial data: setting the record straight
Misleading communication of risk
Finding studies on reboxetine: a tale of hide and seek
Select this articleData availability for industry sponsored trials: what should medical journals require?
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
N Engl J Med, 14 ottobre
Regulatory Action on Rosiglitazone by the U.S. Food and Drug Administration
Reviving the FDA
Legislating against Use of Cost-Effectiveness Information
JAMA, 13 ottobre
Managing Medications in Clinically Complex Elders: "There's Got to Be a Happy Medium"
Medication Use in Older Patients: Better Policy Could Encourage Better Practice
PLoS Med, 12 ottobre
Being More Realistic about the Public Health Impact of Genomic Medicine
4 - 10 ottobre
Lancet, 9 ottobre
FDA: regulators or abdicators?
Measuring and improving health-system productivity
Use of mass media campaigns to change health behaviour
BMJ, 9 ottobre
The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence
JAMA, 6 ottobre
Evaluating the Risks of Clinical Research
What If Physicians Actually Had to Control Medical Costs?
What Physician-Investigators Owe Patients Who Participate in Research
Implementation of the ICMJE Form for Reporting Potential Conflicts of Interest
PLoS Med, 5 ottobre
A Field Training Guide for Human Subjects Research Ethics
Ann Intern Med, 5 ottobre
Comparative Effectiveness Research: A Progress Report
CMAJ, 5 ottobre
A framework for research ethics review during public emergencies
27 settembre - 3 ottobre
BMJ, 2 ottobre
Continuing medical education across Europe
Merging of marketing and medical science: female sexual dysfunction
Maintaining the competence of Europe’s workforce
Impact of workplace based assessment on doctors’ education and performance: a systematic review
Evaluating policy and service interventions: framework to guide selection and interpretation of study end points
Lancet, 2 ottobre
Singapore Statement: a global agreement on responsible research conduct
AGREE II—improving the quality of clinical care
N Engl J Med, 30 settembre
Placebo-Controlled Trials in Osteoporosis — Proceeding with Caution
The Ethics of Placebo in Studies with Fracture End Points in Osteoporosis
Arch Intern Med, 27 settembre
Incidental Findings in Imaging Research: Evaluating Incidence, Benefit, and Burden
Responding to Incidental Findings on Research Imaging Studies: Now What?
10 - 26 settembre
BMJ, 25 settembre
Is it time to revisit orphan drug policies?
Streamlined research governance: are we there yet?
Lancet, 25 settembre
Innovation or regulation: IDEAL opportunity for consensus
Ethical challenges of innovative surgery: a response to the IDEAL recommendations
PLoS Med, 21 settembre
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
Ann Intern Med, 21 settembre
Select this articleClinical Trials: Discerning Hype From Substance
13 - 19 settembre
JAMA, 15 settembre
Theme Issue: Medical Education
Arch Intern Med, 13 settembre
Ambulatory Patient Safety: The Time Is Now
6 - 12 settembre
BMJ, 11 settembre
Licensing drugs for diabetes
FDA guidance on patient reported outcomes
Drug Regulation: Rosiglitazone: what went wrong?
Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
Lancet, 11 settembre
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases
N Engl J Med, 9 settembre
Patient Safety beyond the Hospital
PLoS, 7 settembre
The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
CMAJ, 7 settembre
Competing interests and undergraduate medical education: time for transparency
Ann Intern Med, 7 settembre
The Effect of Financial Incentives on Hospitals That Serve Poor Patients
Does Pay-for-Performance Steal From the Poor and Give to the Rich?
Improving the Quality of Informed Consent: It Is Not All About the Risks
30 agosto - 5 settembre
N Engl J Med, 2 settembre
The Disclosure Dilemma — Large-Scale Adverse Events
JAMA, 1 settembre
A New Research and Development Policy Framework for the Biomedical Research Enterprise
Improving Access to Health Care Data
PLoS Med, 30 agosto
Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders
23 - 29 agosto
BMJ, 28 agosto
Importance of accurately identifying chronic disease in studies using electronic health records
Lancet, 28 agosto
The James Lind Alliance: tackling research mismatches
N Engl J Med, 26 agosto
Revisiting the Rosiglitazone Story — Lessons Learned
JAMA, 25 agosto
The Rational Clinical Examination. Does This Coughing Adolescent or Adult Patient Have Pertussis?
Minimizing Bias Due to Confounding by Indication in Comparative Effectiveness Research: The Importance of Restriction
Comparative Effectiveness—of What?: Evaluating Strategies to Improve Population Health
16 - 22 agosto
BMJ, 21 agosto
Interpreting composite outcomes in trials
Inadequate post-publication review of medical research
Open access publication fees at the BMJ
Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study
Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
Adequacy of authors’ replies to criticism raised in electronic letters to the editor: cohort study
Taking healthcare interventions from trial to practice
N Engl J Med, 19 agosto
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
New Priorities for Future Biomedical Innovations
JAMA, 18 agosto
The Rational Clinical Examination. Does This Patient Have Delirium? Value of Bedside Instruments
The US Global Health Initiative: Informing Policy With Evidence
Minimizing Bias in Randomized Trials: The Importance of Blinding
Physician Compensation, Cost, and Quality
PLoS Med, 17 agosto
The Costs and Underappreciated Consequences of Research Misconduct: A Case Study
9 - 15 agosto
N Engl J Med, 12 agosto
Disclosing Industry Relationships — Toward an Improved Federal Research Policy
Quality Measures and the Individual Physician
Accountability Measures — Using Measurement to Promote Quality Improvement
JAMA, 11 agosto
Evaluation of Comparative Treatment Trials: Assessing Clinical Benefits and Risks for Patients, Rather Than Statistical Effects on Measures
Should Sensitive Information From Clinical Trials Be Included in Electronic Medical Records?
2 - 8 agosto
N Engl J Med, 5 agosto
The “Meaningful Use” Regulation for Electronic Health Records
Finding My Way to Electronic Health Records
Ann Intern Med, 3 agosto
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods
Toward More Uniform Conflict Disclosures: The Updated ICMJE Conflict of Interest Reporting Form
26 luglio - 1 agosto
BMJ, 31 luglio
Improving productivity in the NHS
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Lancet, 31 luglio
Vienna Declaration: a call for evidence-based drug policies
19- 25 luglio
BMJ, 24 luglio
Reorganisation of the NHS in England
Quality Improvement Report. Reducing Clostridium difficile infection in acute care by using an improvement collaborative
N Engl J Med, 22 luglio
Cancer Clinical Trials — A Chronic but Curable Crisis
Ann Intern Med, 20 luglio
Plagiarism in Residency Application Essays
Plagiarism on Personal Statements: A Disturbing Symptom of a Broader Trend
Open Notes: Doctors and Patients Signing On
12 - 18 luglio
JAMA, 14 luglio
Physicians' Perceptions, Preparedness for Reporting, and Experiences Related to Impaired and Incompetent Colleagues
Checklists and Guidelines: Imaging Techniques for Visualizing What to Do
CMAJ, 13 luglio
Toward more uniform conflict disclosures: updated ICMJE conflict of interest reporting form
Are we keeping research participants safe enough?
Development of the AGREE II, part 2: assessment of validity of items and tools to support application
Development of the AGREE II, part 1: performance, usefulness and areas for improvement
5- 11 luglio
N Engl J Med, 8 luglio
Identifying and Eliminating the Roadblocks to Comparative-Effectiveness Research
Toward More Uniform Conflict Disclosures — The Updated ICMJE Conflict of Interest Reporting Form
JAMA, 7 luglio
The Rational Clinical Examination. Can This Patient Read and Understand Written Health Information?
Meaningful Use of Health Information Technology Is Managing Information
Procedure Volume as a Predictor of Surgical Outcomes
Ann Intern Med, 6 luglio
Aggregating and Disaggregating Patients in Clinical Trials and Their Subgroup Analyses
28 giugno - 4 luglio
Lancet, 3 luglio
Putting research into context—revisited
Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting
BMJ, 3 luglio
Towards more uniform conflict disclosures
What attributes should clinical ethics committees have?
Modified intention to treat reporting in randomised controlled trials: systematic review
Arch Intern Med, 28 giugno
When Clinical Practice Guidelines Meet the Black Box
Patient Record Review of the Incidence, Consequences, and Causes of Diagnostic Adverse Events
Diagnostic Adverse Events: On to Chapter 2: Comment on "Patient Record Review of the Incidence, Consequences, and Causes of Diagnostic Adverse Events"
21 - 27 giugno
BMJ, 26 giugno
Do summary care records have the potential to do more harm than good? YES
Do summary care records have the potential to do more harm than good? NO
Random measurement error and regression dilution bias
N Engl J Med, 24 giugno
Transparency at the Food and Drug Administration
JAMA, 23/30 giugno
Adherence to Surgical Care Improvement Project Measures and the Association With Postoperative Infections
Surgical Care Improvement: Should Performance Measures Have Performance Measures
14 - 20 giugno
BMJ, 19 giugno
Should the Quality and Outcomes Framework be abolished? Yes
Should the Quality and Outcomes Framework be abolished? No
Controversy over generic substitution
JAMA, 16 giugno
Managing Financial Conflict of Interest in Biomedical Research
Quality of Care—How Good Is Good Enough?
Payment Policy Based on Measurement of Health Care Spending and Outcomes
7 - 13 giugno
JAMA, 9 giugno
The Rational Clinical Examination. Does This Patient Have a Hemorrhagic Stroke?
PLoS, 8 giugno
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
31 maggio - 6 giugno
BMJ, 5 giugno
How New Zealand has contained expenditure on drugs
JAMA, 2 giugno
Using Science to Improve the Nation's Health System: NIH's Commitment to Comparative Effectiveness Research
Ann Intern Med, 1 giugno
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
24 - 30 maggio
BMJ, 29 maggio
Need for a wider view of autonomy in epidemiological research
An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials
JAMA, 26 maggio
Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
Arch Intern Med, 24 maggio
Transforming Trial Results Into Practice Change
17 - 23 maggio
Lancet, 22 maggio
European Medicines Agency—more transparency needed
Ann Intern Med, 18 maggio
10 - 16 maggio
BMJ, 15 maggio
Community pharmacy: moving from dispensing to diagnosis and treatment
The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators
JAMA, 12 maggio
Health Care Is Different—That's Why Expenditures Matter
Arch Intern Med, 10 maggio
Less Is More: How Less Health Care Can Result in Better Health
3 - 9 maggio
CMAJ, 10 maggio
N Engl J Med, 6 maggio
Effect of Bar-Code Technology on the Safety of Medication Administration
26 aprile - 2 maggio
BMJ, 1 maggio
How can we make audit sexy?
Assessing the quality of hospitals
Has the European Clinical Trials Directive been a success?
Using hospital mortality rates to judge hospital performance: a bad idea that just won’t go away
Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design
N Engl J Med, 29 aprile
Engaging Specialists in Performance-Incentive Programs
JAMA, 28 aprile
What Makes a Good Predictor?: The Evidence Applied to Coronary Artery Calcium Score
PLoS, 27 aprile
Comparative Effectiveness Research: Challenges for Medical Journals
Arch Intern Med, 26 aprile
Public Disclosure of Conflicts of Interest: Moving the Policy Debate Forward
The Impact of Disclosing Financial Ties in Research and Clinical Care: A Systematic Review
Comparative Analysis of Different Approaches to Report Diagnostic Accuracy
19 - 25 aprile
BMJ, 24 aprile
How to identify when a performance indicator has run its course
JAMA 21 aprile
The Rational Clinical Examination. Does This Patient With Diabetes Have Large-Fiber Peripheral Neuropathy?
12 -18 aprile
BMJ, 17 aprile
Improving pharmacovigilance in Europe
Can the NHS cut costs without substantially damaging the quality of health care
Europe’s opportunity to open up drug regulation
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Quality Improvement Report: Using care bundles to reduce in-hospital mortality: quantitative survey
Lancet 17 aprile
A collapse in integrity of scientific advice in the UK
Arch Intern Med, 12 aprile
Cautionary Tales in the Interpretation of Clinical Studies Involving Older Persons
Comparative Effectiveness Research: Critically Intertwined With Health Care Reform and the Future of Biomedical Innovation
5 - 11 aprile
BMJ, 10 aprile
Rosiglitazone, marketing, and medical science
Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review
Lancet, 10 aprile
Strengthening the credibility of clinical research
JAMA, 7 aprile
The Rational Clinical Examination. Will This Patient Develop Persistent Disabling Low Back Pain?
CMAJ, 6 aprile
Strategies to decrease the rate of preventable readmission to hospital
Good prescribing: better systems and prescribers needed
Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community
29 marzo - 4 aprile
BMJ, 3 apriile
Problems with peer review
Lancet, 3 aprile
CONSORT 2010
Improving quality of care in the NHS
Education of health professionals for the 21st century: a global independent Commission
CONSORT 2010 changes and testing blindness in RCTs
N Engl J Med, 1 aprile
Modernizing Device Regulation
Improving the Security and Privacy of Implantable Medical Devices
22 - 28 marzo
JAMA 24/31 marzo
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects: Systematic Review and Meta-regression Analysis
Psychiatrists' Relationships With Pharmaceutical Companies: Part of the Problem or Part of the Solution?
Ensuring Integrity in Industry-Sponsored Research: Primum Non Nocere, Revisited
Setting the RECORD Straight
PLos, 24 marzo
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
Ann Intern Med, 24 marzo
BMJ, 23 marzo
The new CONSORT statement
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
CMAJ, 23 marzo
Effect of point-of-care computer reminders on physician behaviour: a systematic review
Arch Intern Med, 22 marzo
Cancer and the Media. How Does the News Report on Treatment and Outcomes?
Covering Cancer. Comment on "Cancer and the Media"
15 - 21 marzo
N Engl J Med, 18 marzo 2010
Five Next Steps for a New National Program for Comparative-Effectiveness Research
8 - 14 marzo
BMJ, 13 marzo
Graphic medicine: use of comics in medical education and patient care
Will a market deliver quality and efficiency in health care better than central planning ever could?
Lancet, 13 marzo
The role of academic health science systems in the transformation of medicine
JAMA, 10 marzo
Characteristics of Published Comparative Effectiveness Studies of Medications
Building Comparative Efficacy and Tolerability Into the FDA Approval Process
Charting a Path From Comparative Effectiveness Funding to Improved Patient-Centered Health Care
Promoting Science Education
Arch Intern Med, 8 marzo
Patient-Centered Comparative Effectiveness Research: Essential for High-Quality Care
Statistical Numeracy for Health: A Cross-cultural Comparison With Probabilistic National Samples
Collective Statistical Illiteracy: A Cross-Cultural Comparison With Probabilistic National Samples: Comment on "Statistical Numeracy for Health"
1 - 7 marzo
BMJ, 6 marzo
Meta-analysis of individual participant data: rationale, conduct, and reporting
22 - 28 febbraio
BMJ, 27 febbraio
Publishing information about ongoing clinical trials for patients
The routine use of patient reported outcome measures in healthcare settings
N Engl J Med, 25 febbraio
Serving Two Masters — Conflicts of Interest in Academic Medicine
JAMA, 24 febbraio
Registering Clinical Trial Results: The Next Step
CMAJ, 23 febbraio
Measuring performance is essential to patient-centred care
Arch Intern Med, 22 febbraio
Decreasing Hospital Costs While Maintaining Quality: Can It Be Done?
Pharmaceutical Industry Support and Residency Education: A Survey of Internal Medicine Program Directors
16 - 21 febbraio
Lancet, 20 febbraio
Biological, clinical, and ethical advances of placebo effects
BMJ, 20 febbraio
The prognosis for research
Registration of observational studies
Has guideline development gone astray? Yes
Has guideline development gone astray? No
Ten steps towards improving prognosis research
Ann Intern Med, 16 febbraio
Improving Patient Care. Frequency of Inappropriate Medical Exceptions to Quality Measures
PLoS Med, 16 febbraio
Guidance for Developers of Health Research Reporting Guidelines
8 - 15 febbraio
Lancet, 13 febbraio
Evidence-based medicine in China
BMJ, 13 febbraio
Higher hospital volume and specialisation
CMAJ, 12 febbraio
Knowledge creation: synthesis, tools and products
The knowledge-to-action cycle: identifying the gaps
Adapting clinical practice guidelines to local context and assessing barriers to their use
Developing and selecting interventions for translating knowledge to action
Selecting educational interventions for knowledge translation
Monitoring use of knowledge and evaluating outcomes
JAMA, 10 febbraio
Replicating High-Quality Medical Care Organizations
1 - 7 febbraio
Lancet, 6 febbraio
Fabricated or induced illness by carers: a complex conundrum
BMJ, 6 febbraio
Will financial incentives and penalties improve hospital care?
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewer
N Engl J Med, 4 febbraio
Comparative Effectiveness and Health Care Spending — Implications for Reform
JAMA, 3 febbraio
Safe Electronic Health Record Use Requires a Comprehensive Monitoring and Evaluation Framework
Electronic Health Records in the Age of Social Networks and Global Telecommunications
Evidence-Based Medicine Requires Appropriate Clinical Context
PLoS, 2 febbraio
Ghostwriting at Elite Academic Medical Centers in the United States
25 - 31 gennaio
Lancet, 30 gennaio
The perils of journal and supplement publishing
Should protocols for observational research be registered?
A flexible blueprint for the future of drug development
Comparative effectiveness research stalls in the USA
A framework for mandatory impact evaluation to ensure well informed public policy decisions
BMJ, 30 gennaio
NICE and new: appraising innovation
JAMA, 27 gennaio
Continuing Medical Education: Let the Guessing Begin
PLoS, 26 gennaio
Science Must Be Responsible to Society, Not to Politics
Arch Intern Med, 25 gennaio
Drug Safety: Are We Making Progress?: Comment on "Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data"
18- 24 gennaio
BMJ, 23 gennaio
Use of multiperspective qualitative interviews to understand patients’ and carers’ beliefs, experiences, and needs
N Engl J Med, 21 gennaio
Accelerating the Use of Electronic Health Records in Physician Practices
11- 17 gennaio
BMJ, 16 gennaio
Should healthy volunteers in clinical trials be paid according to risk? Yes
Should healthy volunteers in clinical trials be paid according to risk? No
JAMA, 13 gennaio
Funding of US Biomedical Research, 2003-2008
Insights From Trends in Biomedical Research Funding
CMAJ, 12 gennaio
Disseminate time-sensitive research faster
Registering systematic reviews
Arch Intern Med, 11 gennaio
Systematic Review of Guidelines on Cardiovascular Risk Assessment: Which Recommendations Should Clinicians Follow for a Cardiovascular Health Check?
Screening for High-Risk Cardiovascular Disease: A Challenge for the Guidelines
4-10 gennaio
BMJ, 9 gennaio
Is primary care research a lost cause?
Ann Intern Med, 5 gennaio
Spending More to Save More: Interventions to Promote Adherence
PLoS, 5 gennaio
Are Patents Impeding Medical Care and Innovation?
28 dicembre - 3 gennaio
Lancet, 2 gennaio
The financial challenge facing the NHS
Drug development for neglected diseases: pharma's influence
BMJ, 2 gennaio
Aubrey Blumsohn: Academic who took on industry
Bias in identifying and recruiting participants in cluster randomised trials: what can be done?
N Engl J Med, 31 dicembre
Public Reporting of Discharge Planning and Rates of Readmissions
Affiliazioni James Lind Alliance COPE - Committee on Publication Ethics
We are founder member of GIN
VERIFY HERE
Fondazione GIMBE Via Amendola, 2 - 40121 Bologna (Italy) Tel. + 39 051 5883920 Fax +39 051 3372195 E-mail: info@gimbe.org
Editor: Dott. Nino Cartabellotta Site last update: 24/01/2012 Webmaster: Marco Mosti
© Copyright 1996-2011 GIMBE